Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway

  • Authors:
    • Xiao-Yan Zhao
    • Jun-Fa Li
    • Tian-Zuo Li
    • Chu-Xiong Pan
    • Fu-Shan Xue
    • Gu-Yan Wang
  • View Affiliations / Copyright

    Affiliations: Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, P.R. China, Department of Neurobiology, Capital Medical University; Beijing Institute for Brain Disorders, Capital Medical University, Beijing 100069, P.R. China, Department of Anesthesiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, P.R. China, Department of Anesthesiology, Beijing Stomatological Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China
  • Article Number: 1016
    |
    Published online on: July 15, 2021
       https://doi.org/10.3892/etm.2021.10448
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

It has been reported that morphine pretreatment (MP) can exert neuroprotective effects, and that protein kinase C (PKC) participates in the initiation and development of ischemic/hypoxic preconditioning in the brain. However, it remains unknown whether PKC is involved in MP‑induced neuroprotection. The aim of the present study, which included in vivo and in vitro experiments, was to determine whether the conventional γ isoform of PKC (cPKCγ) was involved in the protective effects of MP against cerebral ischemic injury. The present study included an in vivo experiment using a mouse model of middle cerebral artery occlusion and an in vitro experiment using neuroblastoma N2a cells with oxygen‑glucose deprivation (OGD). Furthermore, a cPKCγ antagonist, Go6983, was used to determine the involvement of cPKCγ in the protective effects of MP against cerebral ischemic injury. In the in vivo experiment, neurological deficits, ischemic infarct volume, neural cell damage, apoptosis and caspase‑3 activation were evaluated. In the in vitro experiment, flow cytometry was used to determine the activation of caspase‑3 in N2a cells with OGD. It was found that MP protected against cerebral ischemic injury. However, intracerebroventricular injection of the cPKCγ antagonist before MP attenuated the neuroprotective effect of MP and increased the activation of cleaved caspase‑3. These findings suggested that MP may provide protection against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Dabrowska S, Andrzejewska A, Lukomska B and Janowski M: Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation. 16(178)2019.PubMed/NCBI View Article : Google Scholar

2 

Mergenthaler P, Dirnagl U and Meisel A: Pathophysiology of stroke: Lessons from animal models. Metab Brain Dis. 19:151–167. 2004.PubMed/NCBI View Article : Google Scholar

3 

Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M and van Melle G: Do transient ischemic attacks have a neuroprotective effect? Neurology. 54:2089–2094. 2000.PubMed/NCBI View Article : Google Scholar

4 

de Lau LM, den Hertog HM, van den Herik EG and Koudstaal PJ: Predicting and preventing stroke after transient ischemic attack. Expert Rev Neurother. 9:1159–1170. 2009.PubMed/NCBI View Article : Google Scholar

5 

Rancurel G: Transient ischemic attacks in the elderly: New definition and diagnostic difficulties. Psychol Neuropsychiatr Vieil. 3:17–26. 2005.PubMed/NCBI(In French).

6 

Archer DP, Walker AM, McCann SK, Moser JJ and Appireddy RM: Anesthetic neuroprotection in experimental stroke in rodents: A systematic review and meta-analysis. Anesthesiology. 126:653–665. 2017.PubMed/NCBI View Article : Google Scholar

7 

Zhang J, Haddad GG and Xia Y: delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 885:143–153. 2000.PubMed/NCBI View Article : Google Scholar

8 

Zhang J, Gibney GT, Zhao P and Xia Y: Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol. 282:C1225–C1234. 2002.PubMed/NCBI View Article : Google Scholar

9 

Endoh H, Taga K, Yamakura T, Sato K, Watanabe I, Fukuda S and Shimoji K: Effects of naloxone and morphine on acute hypoxic survival in mice. Crit Care Med. 27:1929–1933. 1999.PubMed/NCBI View Article : Google Scholar

10 

Endoh H, Honda T, Ohashi S and Shimoji K: Naloxone improves arterial blood pressure and hypoxic ventilatory depression, but not survival, of rats during acute hypoxia. Crit Care Med. 29:623–627. 2001.PubMed/NCBI View Article : Google Scholar

11 

Peart JN, Gross ER and Gross GJ: Opioid-induced preconditioning: Recent advances and future perspectives. Vascul Pharmacol. 42:211–218. 2005.PubMed/NCBI View Article : Google Scholar

12 

Mellor H and Parker PJ: The extended protein kinase C superfamily. Biochem J. 332:281–292. 1998.PubMed/NCBI View Article : Google Scholar

13 

Kaleli HN, Ozer E, Kaya VO and Kutlu O: Protein kinase C isozymes and autophagy during neurodegenerative disease progression. Cells. 9(553)2020.PubMed/NCBI View Article : Google Scholar

14 

Bright R and Mochly-Rosen D: The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke. 36:2781–2790. 2005.PubMed/NCBI View Article : Google Scholar

15 

Perez-Pinzon MA, Dave KR and Raval AP: Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain. Antioxid Redox Signal. 7:1150–1157. 2005.PubMed/NCBI View Article : Google Scholar

16 

Kurkinen K, Busto R, Goldsteins G, Koistinaho J and Pérez-Pinzón MA: Isoform-specific membrane translocation of protein kinase C after ischemic preconditioning. Neurochem Res. 26:1139–1144. 2001.PubMed/NCBI View Article : Google Scholar

17 

Niu C, Li J, Cui X, Han S, Zu P, Li H and Xu Q: Changes in cPKC isoform-specific membrane translocation and protein expression in the brain of hypoxic preconditioned mice. Neurosci Lett. 384:1–6. 2005.PubMed/NCBI View Article : Google Scholar

18 

Sun MK, Hongpaisan J, Nelson TJ and Alkon DL: Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains. Proc Natl Acad Sci USA. 105:13620–13625. 2008.PubMed/NCBI View Article : Google Scholar

19 

Voronkov AV and Mamleev AV: Endothelial dysfunction and Protein kinase C activity development interrelation at ischemic injury of a brain. Patol Fiziol Eksp Ter. 60:134–142. 2016.PubMed/NCBI

20 

Zhang N, Yin Y, Han S, Jiang J, Yang W, Bu X and Li J: Hypoxic preconditioning induced neuroprotection against cerebral ischemic injuries and its cPKCγ-mediated molecular mechanism. Neurochem Int. 58:684–692. 2011.PubMed/NCBI View Article : Google Scholar

21 

Wolf R, Koch T, Schulz S, Klutzny M, Schröder H, Raulf E, Bühling F and Höllt V: Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor. Mol Pharmacol. 55:263–268. 1999.PubMed/NCBI View Article : Google Scholar

22 

Mann A, Illing S, Miess E and Schulz S: Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation. Br J Pharmacol. 172:311–316. 2015.PubMed/NCBI View Article : Google Scholar

23 

Vanderschuren LJ, De Vries TJ, Wardeh G, Hogenboom FA and Schoffelmeer AN: A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci. 14:1533–1538. 2001.PubMed/NCBI View Article : Google Scholar

24 

Ferguson SM, Thomas MJ and Robinson TE: Morphine-induced c-fos mRNA expression in striatofugal circuits: Modulation by dose, environmental context, and drug history. Neuropsychopharmacology. 29:1664–1674. 2004.PubMed/NCBI View Article : Google Scholar

25 

Cunningham CL, Bakner L, Schuette LM and Young EA: Morphine and ethanol pretreatment effects on expression and extinction of ethanol-induced conditioned place preference and aversion in mice. Psychopharmacology (Berl). 238:55–66. 2021.PubMed/NCBI View Article : Google Scholar

26 

Blanchard OL and Smoliga JM: Translating dosages from animal models to human clinical trials--revisiting body surface area scaling. FASEB J. 29:1629–1634. 2015.PubMed/NCBI View Article : Google Scholar

27 

Sacchetti B and Bielavska E: Chelerythrine, a specific PKC inhibitor, blocks acquisition but not consolidation and retrieval of conditioned taste aversion in rat. Brain Res. 799:84–90. 1998.PubMed/NCBI View Article : Google Scholar

28 

Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ and Johannes FJ: . Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392:77–80. 1996.PubMed/NCBI View Article : Google Scholar

29 

Muñoz A, Nakazaki M, Goodman JC, Barrios R, Onetti CG, Bryan J and Aguilar-Bryan L: Ischemic preconditioning in the hippocampus of a knockout mouse lacking SUR1-based K(ATP) channels. Stroke. 34:164–170. 2003.PubMed/NCBI View Article : Google Scholar

30 

Rabinstein AA: Update on treatment of acute ischemic stroke. Continuum (Minneap Minn). 26:268–286. 2020.PubMed/NCBI View Article : Google Scholar

31 

Rodriguez R, Santiago-Mejia J, Gomez C and San-Juan ER: A simplified procedure for the quantitative measurement of neurological deficits after forebrain ischemia in mice. J Neurosci Methods. 147:22–28. 2005.PubMed/NCBI View Article : Google Scholar

32 

Wexler EJ, Peters EE, Gonzales A, Gonzales ML, Slee AM and Kerr JS: An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat. J Neurosci Methods. 113:51–58. 2002.PubMed/NCBI View Article : Google Scholar

33 

Ashwal S, Tone B, Tian HR, Cole DJ and Pearce WJ: Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke. 29:1037–1047. 1998.PubMed/NCBI View Article : Google Scholar

34 

Zwerus R and Absalom A: Update on anesthetic neuroprotection. Curr Opin Anaesthesiol. 28:424–430. 2015.PubMed/NCBI View Article : Google Scholar

35 

Thomazeau J, Rouquette A, Martinez V, Rabuel C, Prince N, Laplanche JL, Nizard R, Bergmann JF, Perrot S and Lloret-Linares C: Acute pain factors predictive of post-operative pain and opioid requirement in multimodal analgesia following knee replacement. Eur J Pain. 20:822–832. 2016.PubMed/NCBI View Article : Google Scholar

36 

Murry CE, Richard VJ, Reimer KA and Jennings RB: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 66:913–931. 1990.PubMed/NCBI View Article : Google Scholar

37 

Schultz JE, Rose E, Yao Z and Gross GJ: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 268:H2157–H2161. 1995.PubMed/NCBI View Article : Google Scholar

38 

Gao CJ, Niu L, Ren PC, Wang W, Zhu C, Li YQ, Chai W and Sun XD: Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system. Neuroscience. 202:352–362. 2012.PubMed/NCBI View Article : Google Scholar

39 

Zhao P, Huang Y and Zuo Z: Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol. 65:945–952. 2006.PubMed/NCBI View Article : Google Scholar

40 

Liu Y, Li J, Yang J, Ji F, Bu X, Zhang N and Zhang B: Inhibition of PKCgamma membrane translocation mediated morphine preconditioning-induced neuroprotection against oxygen-glucose deprivation in the hippocampus slices of mice. Neurosci Lett. 444:87–91. 2008.PubMed/NCBI View Article : Google Scholar

41 

Arabian M, Aboutaleb N, Soleimani M, Mehrjerdi FZ, Ajami M and Pazoki-Toroudi H: Role of morphine preconditioning and nitric oxide following brain ischemia reperfusion injury in mice. Iran J Basic Med Sci. 18:14–21. 2015.PubMed/NCBI

42 

Peart JN and Gross GJ: Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am J Physiol Heart Circ Physiol. 291:H1746–H1753. 2006.PubMed/NCBI View Article : Google Scholar

43 

Zhang N, Zhu H, Han S, Sui L and Li J: cPKCγ alleviates ischemic injury through modulating synapsin Ia/b phosphorylation in neurons of mice. Brain Res Bull. 142:156–162. 2018.PubMed/NCBI View Article : Google Scholar

44 

Faubel S and Edelstein CL: Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord. 5:269–287. 2005.PubMed/NCBI View Article : Google Scholar

45 

Eftekhar-Vaghefi S, Esmaeili-Mahani S, Elyasi L and Abbasnejad M: Involvement of Mu opioid receptor signaling in the protective effect of opioid against 6-hydroxydopamine-induced SH-SY5Y human neuroblastoma cells apoptosis. Basic Clin Neurosci. 6:171–178. 2015.PubMed/NCBI

46 

Arabian M, Aboutaleb N, Soleimani M, Ajami M, Habibey R, Rezaei Y and Pazoki-Toroudi H: Preconditioning with morphine protects hippocampal CA1 neurons from ischemia-reperfusion injury via activation of the mTOR pathway. Can J Physiol Pharmacol. 96:80–87. 2018.PubMed/NCBI View Article : Google Scholar

47 

Lu S, Liao L, Zhang B, Yan W, Chen L, Yan H, Guo L, Lu S, Xiong K and Yan J: Antioxidant cascades confer neuroprotection in ethanol, morphine, and methamphetamine preconditioning. Neurochem Int. 131(104540)2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhao X, Li J, Li T, Pan C, Xue F and Wang G: Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway. Exp Ther Med 22: 1016, 2021.
APA
Zhao, X., Li, J., Li, T., Pan, C., Xue, F., & Wang, G. (2021). Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway. Experimental and Therapeutic Medicine, 22, 1016. https://doi.org/10.3892/etm.2021.10448
MLA
Zhao, X., Li, J., Li, T., Pan, C., Xue, F., Wang, G."Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway". Experimental and Therapeutic Medicine 22.3 (2021): 1016.
Chicago
Zhao, X., Li, J., Li, T., Pan, C., Xue, F., Wang, G."Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway". Experimental and Therapeutic Medicine 22, no. 3 (2021): 1016. https://doi.org/10.3892/etm.2021.10448
Copy and paste a formatted citation
x
Spandidos Publications style
Zhao X, Li J, Li T, Pan C, Xue F and Wang G: Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway. Exp Ther Med 22: 1016, 2021.
APA
Zhao, X., Li, J., Li, T., Pan, C., Xue, F., & Wang, G. (2021). Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway. Experimental and Therapeutic Medicine, 22, 1016. https://doi.org/10.3892/etm.2021.10448
MLA
Zhao, X., Li, J., Li, T., Pan, C., Xue, F., Wang, G."Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway". Experimental and Therapeutic Medicine 22.3 (2021): 1016.
Chicago
Zhao, X., Li, J., Li, T., Pan, C., Xue, F., Wang, G."Morphine pretreatment protects against cerebral ischemic injury via a cPKCγ‑mediated anti‑apoptosis pathway". Experimental and Therapeutic Medicine 22, no. 3 (2021): 1016. https://doi.org/10.3892/etm.2021.10448
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team